The effects of fenoldopam on coronary conduit blood flow after coronary artery bypass graft surgery.
AffiliationDepartment of Anesthesia, Cork University Hospital, Wilton, Ireland.
Blood Pressure/drug effects
*Coronary Artery Bypass
Coronary Circulation/*drug effects
Heart Rate/drug effects
MetadataShow full item record
CitationJ Cardiothorac Vasc Anesth. 2001 Feb;15(1):72-6.
JournalJournal of cardiothoracic and vascular anesthesia
AbstractOBJECTIVE: To quantify the effects of fenoldopam, 0.1 microg/kg/min, on left internal mammary artery (LIMA) and saphenous vein blood flow after coronary anastomosis. DESIGN: Prospective, randomized, double-blind, placebo-controlled trial. SETTING: University teaching hospital, single institution. PARTICIPANTS: Thirty-one American Society of Anesthesiologists III patients undergoing elective coronary revascularization. INTERVENTIONS: A perivascular ultrasonic flow probe (Linton Instrumentation, Norfolk, UK) was placed around the LIMA and saphenous vein graft after coronary anastomosis. MEASUREMENTS AND MAIN RESULTS: Immediately before and at 5-minute intervals for 15 minutes after starting the infusion, blood flow was measured in the LIMA and one saphenous vein graft using a transit time ultrasonic flow probe. Heart rate, blood pressure, and central venous pressure were documented at these time points. Administration of fenoldopam, 0.1 microg/kg/min, did not alter heart rate or blood pressure. A small, nonsignificant increase in LIMA blood flow occurred during the 15-minute study period (30 +/- 12 to 35 +/- 10 mL/min) in patients who received fenoldopam. No significant changes occurred in the placebo group. CONCLUSIONS: The findings indicate that fenoldopam, 0.1 microg/kg/min, did not influence coronary conduit blood flow to a clinically significant extent. The small increase in LIMA blood flow may be of greater importance in high-risk patients or in the prevention of coronary arterial spasm.
- Prostaglandin E1 increases the blood flow rate of saphenous vein grafts in patients undergoing off-pump coronary artery bypass grafting.
- Authors: Zhao L, Lu J, Wang C, Zhao W, Qing E, Ma J
- Issue date: 2013 Dec
- The effect of fenoldopam and dopexamine on hepatic blood flow and hepatic function following coronary artery bypass grafting with hypothermic cardiopulmonary bypass.
- Authors: Adluri RK, Singh AV, Skoyles J, Robins A, Hitch A, Baker M, Mitchell IM
- Issue date: 2009 Jun
- Milrinone increases flow in coronary artery bypass grafts after cardiopulmonary bypass: a prospective, randomized, double-blind, placebo-controlled study.
- Authors: Arbeus M, Axelsson B, Friberg O, Magnuson A, Bodin L, Hultman J
- Issue date: 2009 Feb
- Effects of vasoactive drugs on flows through left internal mammary artery and saphenous vein grafts in man.
- Authors: DiNardo JA, Bert A, Schwartz MJ, Johnson RG, Thurer RL, Weintraub RM
- Issue date: 1991 Nov
- Dopexamine increases internal mammary artery blood flow following coronary artery bypass grafting.
- Authors: Flynn MJ, Winter DC, Breen P, O'Sullivan G, Shorten G, O'Connell D, O'Donnell A, Aherne T
- Issue date: 2003 Oct